- Home
- A-Z Publications
- Current Gene Therapy
- Previous Issues
- Volume 22, Issue 1, 2022
Current Gene Therapy - Volume 22, Issue 1, 2022
Volume 22, Issue 1, 2022
-
-
CRISPR Systems Suitable for Single AAV Vector Delivery
Authors: Marta Stevanovic, Elena Piotter, Michelle E. McClements and Robert E. MacLarenAbstract: CRISPR (clustered regularly interspaced short palindromic repeats)/Cas gene editing is a revolutionary technology that can enable the correction of genetic mutations in vivo, providing great promise as a therapeutic intervention for inherited diseases. Adeno-associated viral (AAV) vectors are a potential vehicle for delivering CRISPR/Cas. However, they are restricted by their limited packaging capacity. Identifying s Read More
-
-
-
CircRNAs in Lung Adenocarcinoma: Diagnosis and Therapy
Authors: Lijia Su, Jinying Zhao, Huahua Su, Yanhua Wang, Wenfeng Huang, Xuemei Jiang and Shiyao GaoAbstract: Lung adenocarcinoma (LUAD) is the common histological subtype of non-small-cell lung carcinoma (NSCLC). Circular RNAs (circRNAs) represent a new class of non-coding RNAs (ncRNAs) involved in the development of cancer. Accumulating evidence indicated that a large number of circular RNAs were found to be involved in many biological processes, including tumor initiation, proliferation and progression. These Read More
-
-
-
Genetically-modified Stem Cell in Regenerative Medicine and Cancer Therapy; A New Era
Authors: Ali Hassanzadeh, Somayeh Shamlou, Niloufar Yousefi, Marzieh Nikoo and Javad VerdiAbstract: Recently, genetic engineering by various strategies to stimulate gene expression in a specific and controllable mode is a speedily growing therapeutic approach. Genetic modification of human stem or progenitor cells, such as Embryonic Stem Cells (ESCs), Neural Progenitor Cells (NPCs), Mesenchymal Stem/Stromal Cells (MSCs), and Hematopoietic Stem Cells (HSCs) for direct delivery of specific therapeutic molecu Read More
-
-
-
Roles of M6A Regulators in Hepatocellular Carcinoma: Promotion or Suppression
Authors: Jiamao Chen, Qian Zhang, Ting Liu and Hua TangAbstract: Hepatocellular carcinoma (HCC) is the sixth globally diagnosed cancer with a poor prognosis. Although the pathological factors of hepatocellular carcinoma are well elucidated, the underlying molecular mechanisms remain unclear. N6-methyladenosine (M6A) is adenosine methylation occurring at the N6 site, which is the most prevalent modification of eukaryotic mRNA. Recent studies have shown that M6A Read More
-
-
-
Identification of Gene Signature Associated with Type 2 Diabetes Mellitus by Integrating Mutation and Expression Data
Authors: Zijun Zhu, Xudong Han and Liang ChengBackground: Type 2 Diabetes Mellitus (T2DM) is a chronic disease. The molecular diagnosis should be helpful for the treatment of T2DM patients. With the development of sequencing technology, a large number of differentially expressed genes were identified from expression data. However, the method of machine learning can only identify the local optimal solution as the signature. Objective: The mutation information obtain Read More
-
-
-
TGF-β1-based CRISPR/Cas9 Gene Therapy Attenuates Radiation-induced Lung Injury
Authors: Shuai Zhen, Rong Qiang, Jiaojiao Lu, Xiaoqian Tuo, Xiling Yang and Xu LiBackground: Radiation-induced lung injury (RILI) is lacking effective therapeutic strategies. In this study, we conducted TGF-β1-based CRISPR/Cas9 gene therapy for RILI. Objective: Mouse lungs were irradiated with a single-dose of 20-Gy gamma rays followed by intravenous administration of Ad-CRISPR-TGF-β1 or Ad- CRISPR-Null. Methods: Haematoxylin and eosin staining, as well as Masson staining, were performed to observ Read More
-
-
-
Construction and Optimization of Herpes Simplex Virus Vectors for Central Nervous System Gene Delivery based on CRISPR/Cas9-mediated Genome Editing
Authors: Xinwei Huang, Xiuqing Li, Lijuan Yang, Pengfei Wang, Jingyuan Yan, Zuqing Nie, Yingzheng Gao, Zhiwei Li, Jie Wen and Xia CaoAims: We aim to define parameters that affect the safety and long-term transgene expression of attenuated HSV-1 vectors and optimize the expression cassettes to achieve robust and sustained expression in CNS. Background: Engineered, attenuated Herpes Simplex Virus (HSV) vectors are promising vehicles for gene delivery to the peripheral and central nervous systems. The virus latent promoter (LAP) is commonly us Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
-
Volume 5 (2005)
-
Volume 4 (2004)
-
Volume 3 (2003)
-
Volume 2 (2002)
-
Volume 1 (2001)
Most Read This Month
Article
content/journals/cgt
Journal
10
5
false
en

Most Cited Most Cited RSS feed
-
-
New Hope for Intervertebral Disc Degeneration: Bone Marrow Mesenchymal Stem Cells and Exosomes Derived from Bone Marrow Mesenchymal Stem Cell Transplantation
Authors: Xiao-bo Zhang, Xiang-yi Chen, Jin Qi, Hai-yu Zhou, Xiao-bing Zhao, Yi-cun Hu, Rui-hao Zhang, De-chen Yu, Xi-dan Gao, Ke-ping Wang and Lin Ma
-
- More Less